Shalgli-M 1/500mg, 2/500mg Tablet

Shalgli-M 1/500mg, 2/500mg Tablet

Pack Size:

3 X 10 Tablets

Composition:

  • Each uncoated bilayer tablet contains​ Glimepiride 1mg​ & Metformin (as prolonged release) 500mg 
  • Each uncoated bilayer tablet contains Glimepiride 2mg & Metformin (as prolonged release) 500mg 

Indications:

Management of type 2 diabetes when diet, exercise, and single agent (glimepiride or metformin alone) do not result in adequate glycemic control 

Dosage:

Shalgli M is to be administered once per day during breakfast or the first main meal​. Maximum dose: The highest recommended dose per day should be 6mg of glimepiride and 2000mg of metformin​. In order to avoid hypoglycemia, the starting dose of Shalgli M should not exceed the daily doses of glimepiride or metformin already being taken. 

Side Effects:

Hypoglycaemia, Weight gain 
Pack Size:
3 X 10 Tablets

Composition:
  • Each uncoated bilayer tablet contains​ Glimepiride 1mg​ & Metformin (as prolonged release) 500mg 
  • Each uncoated bilayer tablet contains Glimepiride 2mg & Metformin (as prolonged release) 500mg 


Indications:
Management of type 2 diabetes when diet, exercise, and single agent (glimepiride or metformin alone) do not result in adequate glycemic control 

Dosage:
Shalgli M is to be administered once per day during breakfast or the first main meal​. Maximum dose: The highest recommended dose per day should be 6mg of glimepiride and 2000mg of metformin​. In order to avoid hypoglycemia, the starting dose of Shalgli M should not exceed the daily doses of glimepiride or metformin already being taken. 

Side Effects:
Hypoglycaemia, Weight gain 

Product Range

Health articles

Health Articles

Health Articles

Ghana

Our Jejuri factory was audited and approved by Food & Drugs Authority, Ghana in 2009. Our initial operations in Ghana were limited to an import and re-export hub in Tema Free Trade Zone to service Ghana and other West African Countries.
Optimized with PageSpeed Ninja